EFPIA Disclosure Code Reports
Collaboration between HCP/HCO’s and the pharmaceutical industry has long been a positive driver for advancements in patient care and progression of innovative medicine.
AGB-Pharma discloses Transfers of Value to HCP’s and HCO’s in accordance with its commitment to the EFPIA Disclosure Code and the relevant local codes of practice and/or local legal requirements, and in accordance with all applicable data protection laws and regulations.
AGB-Pharma is responsible for publishing Disclosure Reports for countries in Europe in which it operates, to strengthen the public trust in the relationships between pharmaceutical companies and HCPs and HCOs.
Please choose the country below to access the individual country reports.
SE-MEL-AGB 0037 2023/06